Agilent stock has three
divisions; Life Sciences and Diagnostics, Chemical Analysis, and electronic
Measurement. The company with an
employee base of 20600 operates and serves customers in over 100 countries. The
company had revenues of $6.8 billion in fiscal year 2013. The company’s stock
is traded on the New York Stock Exchange under the ticker symbol “A.”
Major products of the
company are oscilloscopes, logic analyzers, signal generators, automated X-ray
inspection, and others in the Electronic measurement segment. Products such as
DNA microarrays, mass spectrometers, nuclear magnetic resonance, and others in
the Life sciences and chemical analysis segment, and DNA mutation detection,
genotyping, etc. in the Diagnostic segment.
Spinoff
Last year on Sept 19,
2013, Agilent announced that there are plans to separate the company into two
publicly traded ones. The new company will be named Keysight Technologies, Inc.
will be a tax free spinoff of its electronic measurement business. This
separation is expected to get completed by the end of 2014.
This spinoff is
expected to increase Agilent’s fortunes and the company is projected to have revenues
of $6.9 billion to $7.1 billion and non-GAAP earnings of $2.96 to $3.16 per
share. The separation will be beneficial for the company as each of businesses
is strong enough financially to compete on their own on back of quality
products produced by them.
0 comments:
Post a Comment